Results 241 to 250 of about 36,691 (260)
Some of the next articles are maybe not open access.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
Scintigraphic techniques are routinely used for the evaluation of the extent and severity of inflammatory bowel disease. Currently, the radiopharmaceutical of choice is 99mTc-hexamethyl propyleneamine oxime (HMPAO)-leukocytes. We studied the imaging potential of two recently developed 99mTc-labeled agents, polyethylene glycol (PEG)-coated liposomes and
Dams, E.T.M. +7 more
openaire +3 more sources
Scintigraphic techniques are routinely used for the evaluation of the extent and severity of inflammatory bowel disease. Currently, the radiopharmaceutical of choice is 99mTc-hexamethyl propyleneamine oxime (HMPAO)-leukocytes. We studied the imaging potential of two recently developed 99mTc-labeled agents, polyethylene glycol (PEG)-coated liposomes and
Dams, E.T.M. +7 more
openaire +3 more sources
Organ Visualisation with Technetium 99m Preparations
The British Journal of Radiology, 1967Abstract Selected examples are presented in this paper to illustrate the potentialities of the use of some of the 99mTc compounds for organ visualisation. Although no attempt has been made at clinical evaluation, the additional information which can be gained by this means is both useful and impressive to those familiar with the technique.
P. Schenck, I. Kazem, P. Gelinsky
openaire +3 more sources
The Radiopharmaceutical Chemistry of Technetium-99m
2019Technetium-99m (99mTc) is a radiometal that has nearly ideal nuclear properties for diagnostic nuclear medicine imaging, which has helped make it high impact and extensively utilized radionuclide in medicine. 99mTc-based imaging—which can be done using a simple gamma camera or a more advanced 3-D method known as single photon emission computed ...
Denis P. Snider +5 more
openaire +2 more sources
Technetium-99m chelates as radiopharmaceuticals
1996Technetium-99m (99mTc) is currently, and will be in the foreseeable future, the most widely used radionuclide used in virtually all clinical diagnostic Nuclear Medicine laboratories in the world. Several 99mTc radiopharmaceuticals that are routinely used have become important factors in decisions on the diagnosis and treatment of patients with a ...
Silvia S. Jurisson, Wynn A. Volkert
openaire +2 more sources
Use of Technetium–99m in Hepatic Scintillography
Nature, 1965HARPER et al.1 have recently pointed out the excellent possibilities of technetium–99m in medical scintillography.
Degrossi O +4 more
openaire +3 more sources
Scintimammography with technetium-99m tetrofosmin
European Journal of Nuclear Medicine, 1996MANSI, Luigi, RAMBALDI PF
openaire +4 more sources
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
This study compared three radionuclide techniques in distinguishing musculoskeletal infection from noninfectious inflammation.Thirty-five orthopedic patients with suspected musculoskeletal infection were examined using three radionuclide techniques in sequence: triphasic bone scintigraphy, 99mTc radioleukocytes (99mTc-WBC) scintigraphy and 99mTc human ...
F, Palermo +6 more
openaire +1 more source
This study compared three radionuclide techniques in distinguishing musculoskeletal infection from noninfectious inflammation.Thirty-five orthopedic patients with suspected musculoskeletal infection were examined using three radionuclide techniques in sequence: triphasic bone scintigraphy, 99mTc radioleukocytes (99mTc-WBC) scintigraphy and 99mTc human ...
F, Palermo +6 more
openaire +1 more source
Newer Technetium-99m Radiopharmaceuticals
1987Just now, we are having the semicentenary of the discovery of the element 43, later on named “technetium” (1,2). In 1937, Perrier and Segre showed that radioactive isotopes of element 43 could be formed by neutron or deuteron bombardment of molybdenum. They investigated the activity in order to collect some information on the chemistry of 43.
openaire +2 more sources
Technetium-99m Diphosphonate Retention in Hyperparathyroidism
Annals of Internal Medicine, 1980Excerpt To the editor: Fogelman and colleagues (1) show increased total-body retention of technetium-99m diphosphonate in a small group of patients with primary hyperparathyroidism and equate this ...
openaire +3 more sources
Bifunctional Chelators for Technetium-99m
1996Technetium-99m has nearly optimal characteristics as a radionuclide for diagnostic radiopharmaceuticals: (1) a low radiation dose to the patients due to the absence of a-and β-radiation and the short physical half-life (6.02 h), (2) the excellent quality of its scintigraphic images as a result of the favourable energy of its gamma radiation (140.5 keV)
openaire +2 more sources